Nektar Therapeutics
NKTR
#6053
Rank
ยฃ0.78 B
Marketcap
ยฃ23.08
Share price
-7.19%
Change (1 day)
-49.96%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2026 (TTM): -ยฃ5.02

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is -ยฃ5.12. In 2025 the company made an earnings per share (EPS) of -ยฃ7.79 a decrease over its 2024 EPS that were of -ยฃ6.77.

EPS history for Nektar Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ5.02-35.65%
2025-ยฃ7.7915.12%
2024-ยฃ6.77-59.54%
2023-ยฃ16.73-25.89%
2022-ยฃ22.58-31.12%
2021-ยฃ32.7814.86%
2020-ยฃ28.54-1.19%
2019-ยฃ28.88-163.96%
2018ยฃ45.16-725.4%
2017-ยฃ7.22-42.73%
2016-ยฃ12.6183.33%
2015-ยฃ6.8839.53%
2014-ยฃ4.93-69.29%
2013-ยฃ16.05-6.67%
2012-ยฃ17.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ5.10-199.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ0.54-110.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ13.28-359.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-ยฃ1.08-78.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ0.76-114.82%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ5.44-206.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
ยฃ0.46-108.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
-ยฃ0.0000000000-100.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland